Nanoencapsulation of Vaccinium ashei Leaf Extract in Eudragit® RS100-Based Nanoparticles Increases Its In Vitro Antioxidant and In Vivo Antidepressant-like Actions
Pharmaceuticals · 07.01.2023 · 16 (1) · 84
DOI: 10.3390/ph16010084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 07.01.2023. Verfasst von Verciane Schneider Cezarotto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria 97105-900,…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Depression is a major psychiatric disorder in Brazil and worldwide. Vaccinium ashei (V. ashei) leaves are cultivation by-products with high bioactive compound levels. Here, a hydroalcoholic extract of V. ashei leaves (HEV) was associated with Eudragit® RS100-based nanoparticles (NPHEV) to evaluate the in vitro antioxidant and in vivo antidepressant-like effects. Interfacial deposition of the preformed polymer method was used for NPHEV production. The formulations were evaluated regarding physicochemical characteristics, antioxidant activity (DPPH radical scavenging and oxygen radical absorbance capacity), and antidepressant-like action (1–25 mg/kg, single intragastric administration) assessed in forced swimming and tail suspension tests in male Balb-C mice. The NPHEV presented sizes in the nanometric range (144–206 nm), positive zeta potential values (8–15 mV), polydispersity index below 0.2, and pH in the acid range. The phenolic compound content was near the theoretical values, although the rutin presented higher encapsulation efficiency (~95%) than the chlorogenic acid (~60%). The nanoencapsulation improved the HEV antioxidant effect and antidepressant-like action by reducing the immobility time in both behavioral tests. Hence, Eudragit® RS100 nanoparticles containing HEV were successfully obtained and are a promising alternative to manage depression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria 97105-900, RS, Brazil.
- Departamento de Ciências da Saúde, Curso de Farmácia, Universidade Regional Integrada do Alto Uruguai e das Missões, Frederico Westphalen 98400-000, RS, Brazil.
- Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos, Departamento de Tecnologia e Ciência dos Alimentos, Centro de Ciências Rurais, Universidade Federal de Santa Maria, Santa Maria 97105-900, RS, Brazil.
- Departamento de Farmácia, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.
ORCID-Profile: Marcel Henrique Marcondes Sari, Letícia Cruz
Zitieren
APA
Cezarotto, V. S., Franceschi, E. P., Stein, A. C., Emanuelli, T., Maurer, L. H., Sari, M. H. M., Ferreira, L. M., & Cruz, L. (2023). Nanoencapsulation of Vaccinium ashei Leaf Extract in Eudragit® RS100-Based Nanoparticles Increases Its In Vitro Antioxidant and In Vivo Antidepressant-like Actions. Pharmaceuticals, 16(1), 84. https://doi.org/10.3390/ph16010084
Vancouver
Cezarotto VS, Franceschi EP, Stein AC, Emanuelli T, Maurer LH, Sari MHM, et al. Nanoencapsulation of Vaccinium ashei Leaf Extract in Eudragit® RS100-Based Nanoparticles Increases Its In Vitro Antioxidant and In Vivo Antidepressant-like Actions. Pharmaceuticals. 2023;16(1):84. doi:10.3390/ph16010084
BibTeX
@article{Cezarotto2023,
author = {Cezarotto, Verciane Schneider and Franceschi, Eduarda Piovesan and Stein, Ana Cristina and Emanuelli, Tatiana and Maurer, Luana Haselein and Sari, Marcel Henrique Marcondes and Ferreira, Luana Mota and Cruz, Letícia},
title = {Nanoencapsulation of Vaccinium ashei Leaf Extract in Eudragit® RS100-Based Nanoparticles Increases Its In Vitro Antioxidant and In Vivo Antidepressant-like Actions},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {1},
pages = {84},
doi = {10.3390/ph16010084}
}
EUVIMED